References
- Weinberg ED. (1974). Iron and susceptibility to infectious disease. Science, 184(140):952–6.
- Arnold RR, Cole MF, McGhee JR. (1977). A bactericidal effect for human lactoferrin. Science, 197(4300):263–5.
- Jenssen H. (2005). Anti herpes simplex virus activity of lactoferrin/lactoferricin—an example of antiviral activity of antimicrobial protein/peptide. Cell Mol Life Sci, 62(24):3002–13.
- Iigo M, Kuhara T, Ushida Y, Sekine K, Moore MA, Tsuda H. (1999). Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice. Clin Exp Metastasis, 17(1):35–40.
- Togawa J, Nagase H, Tanaka K, Inamori M, Nakajima A, Ueno N, (2002). Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. J Gastroenterol Hepatol, 17(12):1291–8.
- Hayashida K, Kaneko T, Takeuchi T, Shimizu H, Ando K, Harada E. (2004). Oral administration of lactoferrin inhibits inflammation and nociception in rat adjuvant-induced arthritis. J Vet Med Sci, 66(2):149–54.
- Takakura N, Wakabayashi H, Ishibashi H, Yamauchi K, Teraguchi S, Tamura Y, (2004). Effect of orally administered bovine lactoferrin on the immune response in the oral candidiasis murine model. J Med Microbiol, 54:495–500.
- Legrand D, Elass E, Pierce A, Mazurier J. (2004). Lactoferrin and host defence: An overview of its immuno-modulating and anti-inflammatory properties. Biometals, 17(3):225–9.
- Suzuki YA, Lopez V, Lönnerdal B. (2005). Mammalian lactoferrin receptors: Structure and function. Cell Mol Life Sci, 62(22):2560–75.
- Shimizu H. (2004). Development of an enteric-coated lactoferrin tablet and its application. Biometals, 17(3):343–7.
- Takeuchi T, Jyonotsuka T, Kamemori N, Kawano G, Shimizu H, Ando K, (2006). Enteric-formulated lactoferrin was more effectively transported into blood circulation from gastrointestinal tract in adult rats. Exp Physiol, 91(6):1033–40.
- Ishikado A, Imanaka H, Takeuchi T, Harada E, Makino T. (2005). Liposomalization of lactoferrin enhanced it's anti-inflammatory effects via oral administration. Biol Pharm Bull, 28(9):1717–21.
- Kawashima Y, Yamamoto H, Takeuchi H, Kuno Y. (2000). Mucoadhesive DL-lactide/glycolide copolymer nanospheres coated with chitosan to improve oral delivery of elcatonin. Pharm Dev Technol, 5(1):77–85.
- Hori M, Onishi H, Machida Y. (2005). Evaluation of Eudragit-coated chitosan microparticles as an oral immune delivery system. Int J Pharm, 297(1–2):223–34.
- Onishi H, Machida Y, Koyama K. (2007). Preparation and in vitro characteristics of lactoferrin-loaded chitosan microparticles. Drug Dev Ind Pharm, 33(6):641–7.
- Oosegi T, Onishi H, Machida Y. (2008). Novel preparation of enteric-coated chitosan-prednisolone conjugate microspheres and in vitro evaluation of their potential as a colonic delivery system. Eur J Pharm Biopharm, 68(2):260–6.
- Coppi G, Iannuccelli V, Leo E, Bernabei MT, Cameroni R. (2001). Chitosan-alginate microparticles as a protein carrier. Drug Dev Ind Pharm, 27(5):393–400.
- Wittaya-areekul S, Kruenate J, Prahsarn C. (2006). Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone. Int J Pharm, 312(1–2):113–8.
- Mladenovska K, Raicki RS, Janevik EI, Ristoski T, Pavlova MJ, Kavrakovski Z, (2007). Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles. Int J Pharm, 342(1–2):124–36.
- Basu SK, Rajendran A. (2008). Studies in the development of nateglinide loaded calcium alginate and chitosan coated calcium alginate beads. Chem Pharm Bull, 56(8):1077–84.
- Koyama K, Onishi H, Machida Y. (2009). Preparation and in vitro evaluation of chitosan-coated alginate/calcium complex microparticles loaded with fluorescein-labeled lactoferrin. Yakugaku Zasshi, 129(12):1507–14.
- Kubota K, Kamiya H, Kisara K, Sasaki K. (1987). Experimental pharmacology. Tokyo: Nankodo, 154–6.
- Zimecki M, Miedzybrodzki R, Szymaniec S. (1998). Oral treatment of rats with bovine lactoferrin inhibits carrageenan-induced inflammation; correlation with decreased cytokine production. Arch Immunol Ther Exp, 46(6):361–5.
- Nezić L, Skrbić R, Dobrić S, Stojiljković MP, Jaćević V, Satara SS, (2008). Simvastatin and indomethacin have similar anti-inflammatory activity in a rat model of acute local inflammation. Basic Clin Pharmacol Toxicol, 104(3):185–91.
- Sarmento B, Ribeiro A, Veiga F, Sampaio P, Neufeld R, Ferreira D. (2007). Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm Res, 24(12):2198–206.